During the past decade, CancerCare Manitoba - St. Boniface conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CancerCare Manitoba - St. Boniface" are "Amyloid Cardiomyopathy" (1 trials), "Amyloidosis" (1 trials), "Cardiomyopathies" (1 trials), "Heart Diseases" (1 trials) and "Transthyretin Amyloidosis" (1 trials). Many other conditions were trialed in "CancerCare Manitoba - St. Boniface" in a lesser frequency.

Most popular intervention types in "CancerCare Manitoba - St. Boniface" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acoramidis (AG10)" (1 trials), "Placebo Oral Tablet" (1 trials) and "acoramidis" (1 trials). Other intervention names were less common.

The vast majority of trials in "CancerCare Manitoba - St. Boniface" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CancerCare Manitoba - St. Boniface". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in CancerCare Manitoba - St. Boniface, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CancerCare Manitoba - St. Boniface, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".